Hascovir Control Max

Hascovir Control Max is a prescription oral medication that contains the antiviral agent aciclovir. It is supplied in tablet form (strength not specified) and is marketed within the European Union. Aciclovir belongs to the antiviral drug class and works by inhibiting viral DNA polymerase, which blocks replication of herpes viruses. The product is intended for use under medical supervision for conditions caused by herpes simplex and varicella‑zoster viruses.

Hascovir Control Max is indicated for the treatment of infections caused by herpes viruses, where oral antiviral therapy is appropriate.

- Primary genital herpes (HSV‑1 and HSV‑2) infections. - Oral herpes (cold sores) caused by HSV‑1. - Shingles (herpes zoster) resulting from varicella‑zoster virus reactivation. - Suppressive therapy to reduce recurrence of genital herpes. - Treatment of varicella (chickenpox) in immunocompromised patients when oral therapy is preferred. - Post‑exposure prophylaxis for HSV exposure in high‑risk individuals.

Side effects reported with oral aciclovir, the active component of Hascovir Control Max, are generally mild but can vary among patients.

Common: - Nausea or upset stomach. - Headache. - Dizziness. - Mild skin rash.

Serious: - Kidney function impairment or acute renal failure. - Severe allergic reactions such as anaphylaxis. - Blood cell abnormalities (e.g., neutropenia, thrombocytopenia). - Confusion or hallucinations, especially in elderly patients.

Before starting Hascovir Control Max, certain precautions should be considered to ensure safe use and to minimize risk of complications.

- Assess kidney function; dose adjustment may be needed in renal impairment. - Review patient’s medical history for immunosuppression or severe systemic disease. - Use with caution in elderly patients due to higher risk of renal side effects. - Avoid use during pregnancy or breastfeeding unless clearly indicated by a healthcare professional. - Monitor for signs of allergic reaction, especially after the first dose. - Ensure adequate hydration to support renal clearance.

Aciclovir can interact with other medicines, which may affect its effectiveness or increase the risk of adverse effects.

Avoid: - Concomitant use with nephrotoxic agents such as aminoglycoside antibiotics (e.g., gentamicin) or high‑dose NSAIDs, which may increase the risk of kidney injury. - Co‑administration with probenecid, a drug that reduces renal clearance of aciclovir, potentially leading to elevated plasma concentrations.

Use with caution: - Combining aciclovir with other antiviral medications (e.g., valacyclovir or famciclovir) may increase the likelihood of toxicity and should be monitored. - Use with caution in patients receiving cimetidine, as it can raise aciclovir levels by reducing renal excretion. - Patients on immunosuppressive therapy should be closely observed, since altered immune function can affect infection severity and drug response.